Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00793858Phase 4Withdrawn
A Phase 4 trial of ciclesonide in perennial allergic rhinitis (PAR), sponsored by University of Chicago. Planned start Feb 2009; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00793858.